Jardiance: Frequently Asked Questions Answered
Introduction
Jardiance is an anti-diabetic drug used in adults to treat type 2 diabetes. In 2014, the FDA approved this drug. It is used alone or in combination with other anti-diabetic drugs. The FDA accepted Jardiance for decreasing diabetic-associated mortality, especially cardiovascular events associated with type 2 diabetes mellitus.
The drug works by inhibiting sodium-glucose co-transporter-2 found in the proximal part of the kidney. Hence, the drug decreases renal absorption and increases the renal excretion of glucose.
What are the uses of Jardiance?
Jardiance is useful for treating type 2 diabetes mellitus in adult patients. Its glucose-lowering effect through renal excretion is associated with its diuretic properties. The medication reduces sodium levels and volume overload, causing a reduction in blood pressure without increasing the heart rate.
Jardiance is helpful for patients with cardiovascular diseases (CVDs) and type 2 diabetes mellitus and patients with a history of diabetes associated with nephropathy. It is used as a third-line agent along with metformin & insulin as well as a second-line agent along with metformin in patients who cannot tolerate insulin and have a history of weight gain and hypoglycemia.